🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

22 recruiting trials

for Cutaneous Squamous Cell Carcinoma (CSCC)

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC NCT05085496Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Atezolizumab, Stereotactic Body Radiation Therapy TIL Therapy in cSCC and MCC NCT07288073Phase 21 site📍 Boston Karam Khaddour, MD, MS · Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence NCT06692556Phase 328 sites📍 Le Puy-en-Velay📍 Pierre-Bénite📍 Dijon Centre Leon Berard · Tests: Adjuvant radiotherapy Towards Cure Via Only Ultra-short ICB in CSCC NCT06823479Phase 25 sites📍 Maastricht📍 Amsterdam📍 Amsterdam The Netherlands Cancer Institute · Tests: Nivolumab, Ipilumimab ctDNA in Cutaneous Squamous Cell Carcinoma NCT06875609n/a1 site📍 Boston Massachusetts Eye and Ear Infirmary · Tests: Blood and Tissue Collection Ex Vivo Cutaneous SCC NCT07402616NA1 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: ex vivo 3D ultrasonography A Study of VET3-TGI in Patients With Solid Tumors NCT06444815Phase 17 sites📍 Los Angeles📍 Orange📍 Miami KaliVir Immunotherapeutics · Tests: VET3-TGI, Atezolizumab Testing Whether Skin Cancer Has Spread to Nearby Lymph Nodes NCT07746258NA1 site📍 Badalona Germans Trias i Pujol Hospital · Tests: Lymphadenectomy Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy NCT07426484Phase 42 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Cosibelimab, Prednisone, Sirolimus, Everolimus A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors NCT07600476Phase 13 sites📍 Munich📍 Würzburg📍 Münster Kupando GmbH · Tests: KUP-101A Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) NCT05377905Phase 1, Phase 21 site📍 Pittsburgh Falo, Louis, MD · Tests: Microneedle Array Doxorubicin (MNA-D) A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients NCT07286318EARLY Phase 12 sites📍 Pittsburgh📍 Pittsburgh Marissa Lobl · Tests: Topical niacinamide 5% cream, Sunscreen Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational Study NCT06879964n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers NCT05910827Phase 1, Phase 220 sites📍 Sydney📍 Westmead📍 Brisbane Hummingbird Bioscience · Tests: HMBD-001, Docetaxel, Cetuximab Follow-up of a French National Cohort of Patients With Cutaneous Squamous Cell Carcinoma Requiring Systemic Treatment. NCT07606508n/a29 sites📍 Amiens📍 Annecy📍 Besançon University Hospital, Lille · Tests: Systemic treatment A Study of Sigvotatug Vedotin in Advanced Solid Tumors NCT04389632Phase 1158 sites📍 Anchorage📍 Fayetteville📍 Rogers Seagen, a wholly owned subsidiary of Pfizer · Tests: sigvotatug vedotin, pembrolizumab, cisplatin, carboplatin MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer NCT06998342Phase 21 site📍 Burlington University of Vermont Medical Center · Tests: Short course radiation, Active Surveillance Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab. NCT07064330n/a1 site📍 Salamanca Instituto de Investigación Biomédica de Salamanca · Tests: Cemiplimab Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma NCT06585410Phase 353 sites📍 Phoenix📍 Scottsdale📍 Tucson Regeneron Pharmaceuticals · Tests: Cemiplimab, Standard of care A Beta-only IL-2 ImmunoTherapY Study NCT05086692Phase 1, Phase 228 sites📍 San Diego📍 San Francisco📍 Santa Monica Medicenna Therapeutics, Inc. · Tests: MDNA11, Pembrolizumab (KEYTRUDA®) A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision NCT06664151EARLY Phase 12 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Fluzone Trivalent Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma NCT06606028n/a1 site📍 San Francisco University of California, San Francisco · Tests: Blood Specimen Collection, Tumor Tissue Collection, Medical Record Review
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy